Abstract
This study sought to identify genetic cause of spontaneous intraabdominal hemorrhage (SIH) in severe acute pancreatitis (SAP) to develop more effective treatment for this life-threatening complication. A four-phase study was conducted, leveraging a large-scale acute pancreatitis (AP) patients (n=600); the first phase involved whole-exome sequencing analyses, and identified specific exonic variant located in FCGBP (i.e., rs1326680184) that was consistently associated with SIH; the second phase performed serum ELISA tests, and revealed that FCGBP variant altered FCGBP level and further led to predisposition of SIH; the third phase conducted an i) in-vivo experiment with a Fcgbp-knockdown mouse model, and demonstrated lower expression of Fcgbp led to more severe AP morphology and higher risk of hemorrhage; ii) in-vitro experiment with FCGBP-knockdown human vascular fibroblasts demonstrated that down-regulated FCGBP expression could destabilize the vascular wall, and lead to vascular injury in SAP; the fourth phase compared FCGBP variant carriers to non-carriers with clinical characteristics, and found FCGBP variant associated with higher risks of poor complications and AP prognosis and enhanced the diagnostic capability as an indicator. These findings provide important insights into the underlying mechanism of SIH in SAP, and facilitate therapeutic development for AP prognosis and critical care in an early phase.
Highlights
Genetic mutation in FCGBP presents a strong association with predisposition of spontaneous intraabdominal hemorrhage, and provide a novel insight in increasing the severity of acute pancreatitis when knockdown the expression of Fcgbp.
The incorporation of FCGBP mutation as an indicator enhances the ability of clinical assessment with respect to complications and mortality of acute pancreatitis in an early phase before manifestation.
Our findings highlight the gene FCGBP as a probable pathogenic cause of spontaneous intraabdominal hemorrhage in severe acute pancreatitis patients, which enable a development of effective targeted therapies in improving the prognosis and critical care of severe acute pancreatitis.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was funded by the National Natural Science Foundation of China (8207035023, 82204033), Natural Science Foundation of Jiangsu Province (BK20220826).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics Committee of Jinling Hospital, Nanjing, China gave ethical approval for this work.(No.2021NZKY-042-01,No.2022DZGKJDWLS-0059)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The original data and codes used for the current study are available upon reasonable request. The raw sequencing data reported in this study have been being deposited and will be publicly available after this paper is published. All data are provided within the article.
